Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin corrosion: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2018

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Chemical structure
Reference substance name:
Benzyl 2-methoxy-4-prop-1-enylphenyl ether
EC Number:
204-370-6
EC Name:
Benzyl 2-methoxy-4-prop-1-enylphenyl ether
Cas Number:
120-11-6
Molecular formula:
C17H18O2
IUPAC Name:
benzyl 2-methoxy-4-prop-1-enylphenyl ether

In vitro test system

Test system:
human skin model
Amount/concentration applied:
16 mg if the test item
Duration of treatment / exposure:
during 15 minutes for the EPISKIN SM or during 42 minutes for the SkinEthic RHE model
Duration of post-treatment incubation (if applicable):
viability measurements are performed after a 42 hours post-treatment incubation period

Results and discussion

In vitro

Resultsopen allclose all
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
SPL 19
Value:
109.9
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
SPL 20
Value:
126.3
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
SPL 21
Value:
116.1

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
In accordance with the Regulation EC No. 1272/2008, the test item BENZYL ISO EUGENOL has
to be considered as Non-irritant to skin. It corresponds to UN GHS No Category.
No hazard statement or signal word is required.
Executive summary:

The aim was to evaluate the possible irritating effects of the test item BENZYL ISO EUGENOL after topical application on in vitro human reconstructed epidermis (SkinEthic RHE® model).

The test item BENZYL ISO EUGENOL was applied as supplied, at the dose of 16 mg to 3 living Reconstructed Human epidermis (SkinEthic RHE® model) during 42 minutes. The application was followed by a rinse with 25 mL of DPBS and a 42 hours post-incubation period at 37°C, 5% CO2. Cell viability was then measured by enzymatic conversion of the vital dye MTT into a blue formazan salt that was quantitatively measured after extraction from tissues.

The experimental protocol was established in accordance with O.E.C.D. Test Guideline No. 439 adopted 28 July 2015 and the Test method B.46 of Council regulation No. 761/2009 dated

23 July 2009 (EU Journal L220) - ATP Council regulation No. 440/2008 of 30 May 2008 (E.U. Journal L142).

The mean percent viability of the treated tissues was 117.4% (considered as 100%), versus 1.7 % in the positive control (5% Sodium Dodecyl Sulfate).

In accordance with the Regulation EC No. 1272/2008, the test item BENZYL ISO EUGENOL has to be considered as Non-irritant to skin. It corresponds to UN GHS No Category.

No hazard statement or signal word is required.